Wouter Joustra
Direttore/Membro del Consiglio presso ENGENE HOLDINGS INC.
Patrimonio netto: - $ in data 31/05/2024
Posizioni attive di Wouter Joustra
Società | Posizione | Inizio | Fine |
---|---|---|---|
ENGENE HOLDINGS INC. | Direttore/Membro del Consiglio | 15/05/2024 | - |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investitore di Private Equity | 01/10/2019 | - |
Storia della carriera di Wouter Joustra
Precedenti posizioni note di Wouter Joustra
Società | Posizione | Inizio | Fine |
---|---|---|---|
VECTIVBIO HOLDING AG | Direttore/Membro del Consiglio | 09/12/2022 | 26/06/2023 |
Independent Dir/Board Member | 09/12/2022 | 26/06/2023 | |
GYROSCOPE THERAPEUTICS HOLDINGS PLC | Direttore/Membro del Consiglio | 01/03/2021 | 17/02/2022 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Direttore/Membro del Consiglio | 29/03/2021 | 08/10/2021 |
Kempen & Co. USA, Inc.
Kempen & Co. USA, Inc. Investment Banks/BrokersFinance Founded in 1995, Kempen & Co., USA, Inc. is an SEC-registered broker/dealer located in New York City. The firm is a wholly-owned 100% subsidiary of Kempen & Co. NA, an Amsterdam-based merchant bank that was founded in 1903. Kempen & Co. USA focuses on Benelux equities (home-market), European real estate equities, European clean Technology and biotechnology equities. The firm's research includes equity and property reports, daily comments, technical analysis, strategic overviews and complete sector reports. Kempen & Co. USA provides services to institutional clients. The firm is a member of FINRA. | Corporate Officer/Principal | - | - |
FORN EUROPAR | Direttore/Membro del Consiglio | - | - |
Direttore degli Investimenti | - | - |
Formazione di Wouter Joustra
University of Groningen | Graduate Degree |
University of Nebraska | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Regno Unito | 3 |
Germania | 2 |
Posizioni
Director/Board Member | 6 |
Undergraduate Degree | 2 |
Private Equity Investor | 1 |
Settori
Health Technology | 5 |
Finance | 4 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ENGENE HOLDINGS INC. | Health Technology |
Aziende private | 6 |
---|---|
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Finance |
Gyroscope Therapeutics Holdings Plc
Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Forbion European Acquisition Corp.
Forbion European Acquisition Corp. Financial ConglomeratesFinance Forbion European Acquisition Corp. is a blank check company. It engages in the business of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded by Hugo Alexander Slootweg in 2006 and is headquartered in Wilmington, DE. | Finance |
Kempen & Co. USA, Inc.
Kempen & Co. USA, Inc. Investment Banks/BrokersFinance Founded in 1995, Kempen & Co., USA, Inc. is an SEC-registered broker/dealer located in New York City. The firm is a wholly-owned 100% subsidiary of Kempen & Co. NA, an Amsterdam-based merchant bank that was founded in 1903. Kempen & Co. USA focuses on Benelux equities (home-market), European real estate equities, European clean Technology and biotechnology equities. The firm's research includes equity and property reports, daily comments, technical analysis, strategic overviews and complete sector reports. Kempen & Co. USA provides services to institutional clients. The firm is a member of FINRA. | Finance |
VectivBio Holding AG
VectivBio Holding AG Pharmaceuticals: MajorHealth Technology VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. It operates through Switzerland, Canada, and the United States geographical segment. The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Wouter Joustra
- Esperienza